[HTML][HTML] NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds
C Guan, X Zhou, H Li, X Ma, J Zhuang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Polyphenol compounds are natural antioxidants, which are rich in anti-inflammatory and
antioxidant components. They have a wide range of medicinal benefits that are believed to …
antioxidant components. They have a wide range of medicinal benefits that are believed to …
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Y Xue, X Jiang, J Wang, Y Zong, Z Yuan, S Miao… - Biomarker …, 2023 - Springer
Head and neck cancer is a malignant tumour with a high mortality rate characterized by late
diagnosis, high recurrence and metastasis rates, and poor prognosis. Head and neck …
diagnosis, high recurrence and metastasis rates, and poor prognosis. Head and neck …
H3K27me3 conditions chemotolerance in triple-negative breast cancer
The persistence of cancer cells resistant to therapy remains a major clinical challenge. In
triple-negative breast cancer, resistance to chemotherapy results in the highest recurrence …
triple-negative breast cancer, resistance to chemotherapy results in the highest recurrence …
The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer
Thirty-four years since its discovery, NF-κB remains a transcription factor with great potential
for cancer therapy. However, NF-κB–targeted therapies have yet to find a way to be clinically …
for cancer therapy. However, NF-κB–targeted therapies have yet to find a way to be clinically …
Pyrrolidine dithiocarbamate-loaded electrospun membranes for peritendinous anti-adhesion through inhibition of the nuclear factor-κB pathway
M Lu, S Wang, H Wang, T Xue, C Cai, C Fan, F Wu… - Acta Biomaterialia, 2023 - Elsevier
Peritendinous adhesion is a major cause of limb dysfunction and disability in clinical
practice. Numerous studies suggest that activation of nuclear factor-κB (NF-κB) pathway in …
practice. Numerous studies suggest that activation of nuclear factor-κB (NF-κB) pathway in …
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF …
Q Ling, S Wu, X Liao, C Liu, Y Chen - BMC cancer, 2022 - Springer
Background Drug resistance is a considerable challenge for chemotherapy in non-small cell
lung cancer (NSCLC). Propofol, a commonly used intravenous anesthetics, has been …
lung cancer (NSCLC). Propofol, a commonly used intravenous anesthetics, has been …
The NF-κB pharmacopeia: Novel strategies to subdue an intractable target
D Verzella, J Cornice, P Arboretto, D Vecchiotti… - Biomedicines, 2022 - mdpi.com
NF-κB transcription factors are major drivers of tumor initiation and progression. NF-κB
signaling is constitutively activated by genetic alterations or environmental signals in many …
signaling is constitutively activated by genetic alterations or environmental signals in many …
Targeting ROS-AMPK pathway by multiaction Platinum (IV) prodrugs containing hypolipidemic drug bezafibrate
X Qiao, YY Gao, LX Zheng, XJ Ding, LW Xu… - European Journal of …, 2021 - Elsevier
Alterations in lipid metabolism, commonly disregarded in the past, have been accepted as a
hallmark for cancer. Exploring cancer therapeutics that interrupt the lipid metabolic pathways …
hallmark for cancer. Exploring cancer therapeutics that interrupt the lipid metabolic pathways …